Showing 591-600 of 2393 results for "".
Antisense Oligonucleotide Therapies
https://practicalneurology.com/diseases-diagnoses/movement-disorders/antisense-oligonucleotide-therapies/31573/Antisense oligonucleotides are a promising new therapeutic class being studied for the treatment of movement disorders.The Multiple Sclerosis Lesion Checklist
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/the-multiple-sclerosis-lesion-checklist/30216/A clinician's guide to evaluating brain MRI in a patient with improbable multiple sclerosis.Epilepsy Essentials: Neuromodulation for Drug-Resistant Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/epilepsy-essentials-neuromodulation-for-drug-resistant-epilepsy/31805/Neuromodulation devices provide options for individuals with drug-resistant epilepsy not suited, or not responsive, to resective treatment.Single Isolated Concussion Part I: Definitions, Classification, and Prognosis
https://practicalneurology.com/diseases-diagnoses/tbi/single-isolated-concussion-part-i-definitions-classification-and-prognosis/30268/Providing sound advice after a single isolated concussion.Full Disclosure: How To Apologize For Medical Errors
https://practicalneurology.com/columns/practice-management/full-disclosure-how-to-apologize-for-medical-errors/30789/Of all the bad news physicians give patients, “I'm sorry” seems the most dangerous. Here, we look at how to confront disclosure and why the gold standard treatment for a medical error should be an apologyThe Effects of Obesity on Brain Structure and Size
https://practicalneurology.com/diseases-diagnoses/headache-pain/the-effects-of-obesity-on-brain-structure-and-size/30714/An examination of both the pathophysiology of the link between obesity and brain injury, and available strategies that may reverse it.Oral Disease Modifying Therapy for MS: Important Considerations
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/oral-disease-modifying-therapy-for-ms-important-considerations/30827/The availability of an oral agent for MS may create a therapeutic dilemma for clinicians as they try to determine the role of new therapy in patient care.Diagnosis and Management of Neurodegenerative Atypical Parkinsonism
https://practicalneurology.com/diseases-diagnoses/movement-disorders/diagnosis-and-management-of-neurodegenerative-atypical-parkinsonism/30455/EMG and Nerve Conduction Studies in Clinical Practice
https://practicalneurology.com/diseases-diagnoses/neuromuscular/emg-and-nerve-conduction-studies-in-clinical-practice/30863/Electrodiagnostic studies are helpful in evaluating weakness, muscle wasting, and sensory symptoms. More specific questions may allow more detailed and directed conclusions.Monoclonal Antibodies and Migraine: What the Neurologist Needs to Know
https://practicalneurology.com/diseases-diagnoses/headache-pain/monoclonal-antibodies-and-migraine-what-the-neurologist-needs-to-know/30361/As a new age in headache medicine is set to begin, it is incumbent upon neurologists to become better familiarized with and explore the implications of monoclonal antibodies in patient care.